Contact
      Please use this form to send email to PR contact of this press release:
      
      PERTHERA ANNOUNCES LANDMARK STUDY SHOWING MULTI-OMIC TESTING’S ROLE IN IMPROVING OUTCOMES FOR METASTATIC BREAST CANCER
    
      TO:
      
      Marketing Division
      
      Perthera Inc
      
      +1 703-286-0780